Skip to main content
An official website of the United States government

Combined Breast MRI and Biomarker Strategies in Identifying High-risk Breast Cancer Patients

Research Group
Cancer Biomarkers
Sponsor
City of Hope Medical Center
Status
Active, not recruiting
NCT ID
NCT03303846
This clinical trial studies normal breast tissue changes combined with breast magnetic resonance imaging (MRI) that may suggest the beginnings of cancer development. Using breast tissue markers in combination with breast imaging such as MRI may help to more accurately assess a woman's risk of developing breast cancer.
Intervention
Biospecimen Collection, Laboratory Biomarker Analysis, Magnetic Resonance Imaging
Condition
Healthy Subject
Investigators
Victoria Seewaldt, MD

See list of participating sites